A sublingual spray that contains both CBD and THC “could be a new therapeutic agent for lipid and glycemic control in diabetic patients”, according to a double-blind, placebo-controlled clinical trial published by the Iranian Journal of Pharmaceutical Research, and epublished by the U.S. National Library of Medicine. Conducted by researchers at Shahid Beheshti University of …